These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8003286)

  • 21. Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents.
    Hawkins DS; Demers GW; Galloway DA
    Cancer Res; 1996 Feb; 56(4):892-8. PubMed ID: 8631030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional inactivation of p53 by human T-cell leukemia virus type 1 Tax protein: mechanisms and clinical implications.
    Tabakin-Fix Y; Azran I; Schavinky-Khrapunsky Y; Levy O; Aboud M
    Carcinogenesis; 2006 Apr; 27(4):673-81. PubMed ID: 16308315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of p53 and retinoblastoma gene in high-grade nodal peripheral T-cell lymphomas: immunohistochemical and molecular findings suggesting different pathogenetic pathways and possible clinical implications.
    Pescarmona E; Pignoloni P; Santangelo C; Naso G; Realacci M; Cela O; Lavinia AM; Martelli M; Russo MA; Baroni CD
    J Pathol; 1999 Aug; 188(4):400-6. PubMed ID: 10440751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53: an overview of over two decades of study.
    Cheah PL; Looi LM
    Malays J Pathol; 2001 Jun; 23(1):9-16. PubMed ID: 16329542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations.
    Petit B; Leroy K; Kanavaros P; Boulland ML; Druet-Cabanac M; Haioun C; Bordessoule D; Gaulard P
    Hum Pathol; 2001 Feb; 32(2):196-204. PubMed ID: 11230707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the retinoblastoma (RB) tumor suppressor gene inhibits tumor cell invasion in vitro.
    Li J; Hu SX; Perng GS; Zhou Y; Xu K; Zhang C; Seigne J; Benedict WF; Xu HJ
    Oncogene; 1996 Dec; 13(11):2379-86. PubMed ID: 8957079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sodium butyrate modulates p53 and Bcl-2 expression in human retinoblastoma cell lines.
    Madigan MC; Chaudhri G; Penfold PL; Conway RM
    Oncol Res; 1999; 11(7):331-7. PubMed ID: 10757447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumour p53 mutations exhibit promoter selective dominance over wild type p53.
    Monti P; Campomenosi P; Ciribilli Y; Iannone R; Inga A; Abbondandolo A; Resnick MA; Fronza G
    Oncogene; 2002 Mar; 21(11):1641-8. PubMed ID: 11896595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the retinoblastoma protein in cell cycle arrest mediated by a novel cell surface proliferation inhibitor.
    Enebo DJ; Fattaey HK; Moos PJ; Johnson TC
    J Cell Biochem; 1994 Jun; 55(2):200-8. PubMed ID: 8089195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry.
    Sage J; Miller AL; Pérez-Mancera PA; Wysocki JM; Jacks T
    Nature; 2003 Jul; 424(6945):223-8. PubMed ID: 12853964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Pezcoller lecture: cancer cell cycles revisited.
    Sherr CJ
    Cancer Res; 2000 Jul; 60(14):3689-95. PubMed ID: 10919634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gain-of-function mutations in the tumor suppressor gene p53.
    van Oijen MG; Slootweg PJ
    Clin Cancer Res; 2000 Jun; 6(6):2138-45. PubMed ID: 10873062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour suppressor genes and molecular chaperones.
    Lane DP; Midgley C; Hupp T
    Philos Trans R Soc Lond B Biol Sci; 1993 Mar; 339(1289):369-72; discussion 372-3. PubMed ID: 8493291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands.
    Shintani S; Mihara M; Nakahara Y; Kiyota A; Yoshihama Y; Ueyama Y; Matsumura T
    Anticancer Res; 2000; 20(3B):2169-75. PubMed ID: 10928172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cooperative tumorigenic effects of germline mutations in Rb and p53.
    Williams BO; Remington L; Albert DM; Mukai S; Bronson RT; Jacks T
    Nat Genet; 1994 Aug; 7(4):480-4. PubMed ID: 7951317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cell cycle regulation by anti-oncogene].
    Akiyama T
    Tanpakushitsu Kakusan Koso; 1994 Sep; 39(12):2158-62. PubMed ID: 7938611
    [No Abstract]   [Full Text] [Related]  

  • 37. [Molecular cancer epidemiology--the present status and future possibilities].
    Sakai T
    Nihon Eiseigaku Zasshi; 1996 Feb; 50(6):1036-46. PubMed ID: 8720930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of the p53 and Rb-1 genes in cancer, development and apoptosis.
    Hooper ML
    J Cell Sci Suppl; 1994; 18():13-7. PubMed ID: 7883788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor suppressor genes: a new era for molecular genetic studies of cancer.
    Lee EY
    Breast Cancer Res Treat; 1991 Sep; 19(1):3-13. PubMed ID: 1756264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Knights of the Round Table hypothesis of tumour suppressor gene function--noble sacrifice or sexual dalliance: genes, including p53, BRCA1/2 and RB have evolved by horizontal and vertical transmission of mating factor genes and are involved in gametogenesis, implantation, development and tumourigenesis.
    Gosden CM; Liloglou T; Nunn J; Gardener D; Nickson P; Crampton JM; Field JK
    Int J Oncol; 1998 Jan; 12(1):5-35. PubMed ID: 9454883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.